These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12617928)

  • 1. Bis-sulfonamides as endothelin receptor antagonists.
    Boss C; Bolli MH; Weller T; Fischli W; Clozel M
    Bioorg Med Chem Lett; 2003 Mar; 13(5):951-4. PubMed ID: 12617928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethenesulfonamide derivatives, a novel class of orally active endothelin-A receptor antagonists.
    Harada H; Kazami J; Watanuki S; Tsuzuki R; Sudoh K; Fujimori A; Tanaka A; Tsukamoto S; Yanagisawa I
    Chem Pharm Bull (Tokyo); 2001 May; 49(5):606-12. PubMed ID: 11383615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent and selective ET-A antagonists. 1. Syntheses and structure-activity relationships of N-(6-(2-(aryloxy)ethoxy)-4-pyrimidinyl)sulfonamide derivatives.
    Morimoto H; Shimadzu H; Kushiyama E; Kawanishi H; Hosaka T; Kawase Y; Yasuda K; Kikkawa K; Yamauchi-Kohno R; Yamada K
    J Med Chem; 2001 Oct; 44(21):3355-68. PubMed ID: 11585441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and synthesis of a potent sulfonamide ET(B) selective antagonist.
    Kanda Y; Takahashi T; Araki Y; Konoike T; Mihara S; Fujimoto M
    Bioorg Med Chem Lett; 2000 Aug; 10(16):1875-8. PubMed ID: 10969989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dipeptide sulfonamides as endothelin ETA/ETB receptor antagonists.
    Ksander GM; Shetty SS; DelGrande D; Balwierczak JL; Bruseo CW; Savage P; deJesus R; Yuan A; Webb RL; Jeng AY
    Can J Physiol Pharmacol; 2002 May; 80(5):464-9. PubMed ID: 12056554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelin B receptor-mediated vasoconstriction induced by endothelin A receptor antagonist.
    Zhang Y; Oliver JR; Horowitz JD
    Cardiovasc Res; 1998 Sep; 39(3):665-73. PubMed ID: 9861310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of sulfonylamido pyrimidines incorporating an unsaturated side chain as endothelin receptor antagonists.
    Bolli MH; Boss C; Clozel M; Fischli W; Hess P; Weller T
    Bioorg Med Chem Lett; 2003 Mar; 13(5):955-9. PubMed ID: 12617929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biphenylsulfonamide endothelin receptor antagonists. Part 3: structure-activity relationship of 4'-heterocyclic biphenylsulfonamides.
    Murugesan N; Gu Z; Stein PD; Spergel S; Bisaha S; Liu EC; Zhang R; Webb ML; Moreland S; Barrish JC
    Bioorg Med Chem Lett; 2002 Feb; 12(4):517-20. PubMed ID: 11844662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ETA and ETB receptors mediate contraction to endothelin-1 in renal artery of aging SHR. Effects of FR139317 and bosentan.
    Seo B; Lüscher TF
    Hypertension; 1995 Apr; 25(4 Pt 1):501-6. PubMed ID: 7721390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemodynamic influence and endothelin-1 plasma concentrations by selective or non-selective endothelin receptor antagonists in the pig in vivo.
    Holm P; Franco-Cereceda A
    Acta Physiol Scand; 1999 Feb; 165(2):163-8. PubMed ID: 10090327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro characterisation of Ro 46-8443, the first non-peptide antagonist selective for the endothelin ETB receptor.
    Breu V; Clozel M; Burri K; Hirth G; Neidhart W; Ramuz H
    FEBS Lett; 1996 Mar; 383(1-2):37-41. PubMed ID: 8612786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Ro 47-0203 and PD155080 on the plasma kinetics, receptor binding and vascular effects of endothelin in the pig.
    Hemsén A; Modin A; Wanecek M; Malmström RE; Weitzberg E
    Eur J Pharmacol; 1996 Dec; 318(2-3):369-76. PubMed ID: 9016927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelin receptor subtypes in small arteries. Studies with FR139317 and bosentan.
    Takase H; Moreau P; Lüscher TF
    Hypertension; 1995 Apr; 25(4 Pt 2):739-43. PubMed ID: 7721425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure and vascular effects of endothelin blockade in chronic nitric oxide-deficient hypertension.
    Moreau P; Takase H; Küng CF; Shaw S; Lüscher TF
    Hypertension; 1997 Mar; 29(3):763-9. PubMed ID: 9052893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethenesulfonamide and ethanesulfonamide derivatives, a novel class of orally active endothelin-A receptor antagonists.
    Harada H; Kazami J; Watanuki S; Tsuzuki R; Sudoh K; Fujimori A; Sanagi M; Orita M; Nakahara H; Shimaya J; Tsukamoto S; Tanaka A; Yanagisawa I
    Bioorg Med Chem; 2001 Nov; 9(11):2955-68. PubMed ID: 11597477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin B receptor-mediated regulation of endothelin-1 content and release in cultured porcine aorta endothelial cell.
    Sanchez R; MacKenzie A; Farhat N; Nguyen TD; Stewart DJ; Mercier I; Calderone A; Thorin E
    J Cardiovasc Pharmacol; 2002 May; 39(5):652-9. PubMed ID: 11973408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterization of TA-0201, an endothelin receptor antagonist, with recombinant and human prostate endothelin receptors.
    Takahashi M; Taniguchi T; Tanaka T; Kanamaru H; Okada K; Muramatsu I
    Eur J Pharmacol; 2003 Apr; 467(1-3):185-9. PubMed ID: 12706473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a region of the human endothelin ETA receptor required for interaction with bosentan.
    Adachi M; Furuichi Y; Miyamoto C
    Eur J Pharmacol; 1994 Oct; 269(2):225-34. PubMed ID: 7851498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin-1-induced venous contraction is maintained in DOCA-salt hypertension; studies with receptor agonists.
    Watts SW; Fink GD; Northcott CA; Galligan JJ
    Br J Pharmacol; 2002 Sep; 137(1):69-79. PubMed ID: 12183332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of endothelin in experimental cerebral vasospasm.
    Roux S; Löffler BM; Gray GA; Sprecher U; Clozel M; Clozel JP
    Neurosurgery; 1995 Jul; 37(1):78-85; discussion 85-6. PubMed ID: 8587695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.